News & Media

Media

FEATURED

Defence Therapeutics: Our Vaccine Treatment

FEATURED

Defence Therapeutics announces 2 clinical trials for 2023

Developing Next Generation Biopharmaceutical Innovations

Making a Global Impact

Defence Therapeutics Family Office Presentation – London UK

Defence Therapeutics spotlight on BTV

News Releases

Defence Financing

Defence Financing

Vancouver, BC, Canada, January 19th, 2024 - Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), one of the leading Canadian biotechnology companies working in the field of immune-oncology announces, further to its news release...

read more
Defence’s Accutox® Impairs Lung Cancer Growth

Defence’s Accutox® Impairs Lung Cancer Growth

Vancouver, BC, Canada, January 10th, 2024 - Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), one of the leading Canadian biotechnology companies working in the field of immune-oncology is pleased to announce that it...

read more